Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry
O Gautschi, J Milia, T Filleron, J Wolf… - Journal of Clinical …, 2017 - ascopubs.org
Purpose In addition to prospective trials for non–small-cell lung cancers (NSCLCs) that are
driven by less common genomic alterations, registries provide complementary information …
driven by less common genomic alterations, registries provide complementary information …
[HTML][HTML] Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry
O Gautschi, J Milia, T Filleron, J Wolf… - Journal of Clinical …, 2017 - ncbi.nlm.nih.gov
Purpose In addition to prospective trials for non–small-cell lung cancers (NSCLCs) that are
driven by less common genomic alterations, registries provide complementary information …
driven by less common genomic alterations, registries provide complementary information …
Targeting RET in patients with RET-rearranged lung cancers: Results from the global, multicenter RET registry
O Gautschi, J Milia, T Filleron… - Journal of Clinical …, 2017 - ohiostate.elsevierpure.com
Purpose: In addition to prospective trials for non-small-cell lung cancers (NSCLCs) that are
driven by less common genomic alterations, registries provide complementary information …
driven by less common genomic alterations, registries provide complementary information …
[HTML][HTML] Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry.
O Gautschi, J Milia, T Filleron, J Wolf… - Journal of clinical …, 2017 - folia.unifr.ch
English Purpose In addition to prospective trials for non-small-cell lung cancers (NSCLCs)
that are driven by less common genomic alterations, registries provide complementary …
that are driven by less common genomic alterations, registries provide complementary …
[引用][C] Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry
O Gautschi, J Milia, T Filleron, J Wolf, DP Carbone… - 2017 - repository.ubn.ru.nl
Purpose In addition to prospective trials for non-small-cell lung cancers (NSCLCs) that are
driven by less common genomic alterations, registries provide complementary information …
driven by less common genomic alterations, registries provide complementary information …
Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry
O Gautschi, J Milia, T Filleron, J Wolf… - J. Clin …, 2017 - kups.ub.uni-koeln.de
Purpose In addition to prospective trials for non-small-cell lung cancers (NSCLCs) that are
driven by less common genomic alterations, registries provide complementary information …
driven by less common genomic alterations, registries provide complementary information …
Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry
O Gautschi, J Milia, T Filleron, J Wolf… - Journal of clinical …, 2017 - pubmed.ncbi.nlm.nih.gov
Purpose In addition to prospective trials for non-small-cell lung cancers (NSCLCs) that are
driven by less common genomic alterations, registries provide complementary information …
driven by less common genomic alterations, registries provide complementary information …
Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry
O Gautschi, J Milia, T Filleron, J Wolf, DP Carbone… - Journal of Clinical … - sonar.ch
English Purpose In addition to prospective trials for non–small-cell lung cancers (NSCLCs)
that are driven by less common genomic alterations, registries provide complementary …
that are driven by less common genomic alterations, registries provide complementary …
Targeting RET in patients with RET-rearranged lung cancers: Results from the global, multicenter RET registry
O Gautschi, J Milia, T Filleron, J Wolf… - Journal of Clinical …, 2017 - yonsei.elsevierpure.com
Purpose: In addition to prospective trials for non-small-cell lung cancers (NSCLCs) that are
driven by less common genomic alterations, registries provide complementary information …
driven by less common genomic alterations, registries provide complementary information …
Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry.
O Gautschi, J Milia, T Filleron, J Wolf… - Journal of Clinical …, 2017 - europepmc.org
Purpose In addition to prospective trials for non-small-cell lung cancers (NSCLCs) that are
driven by less common genomic alterations, registries provide complementary information …
driven by less common genomic alterations, registries provide complementary information …